Herbalife Ltd. (HLF) SEC Filings & Earnings Calls
EquiReason read 13 Herbalife Ltd. SEC filings in the last 12 months. Latest: 8-K on 2026-08-31 — CEO Stephan Gratziani to transition from role effective Oct 31, 2026, announced Aug 31, 2026. Departure of top executive signals potential strategic shift or instability..
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
- Market cap
- 1.4B
- P/E TTM
- 8.6
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 2 Nov, in 9 days
Every filing, read
last 12 months · SECWhat happened, the numbers inside, guidance and risks. The original is one click away.
31 Aug 20268-K · 5.02CEO Stephan Gratziani to transition from role effective Oct 31, 2026, announced Aug 31, 2026. Departure of top executive signals potential strategic shift or instability.open
Risks flagged
CEO departure risk: loss of strategic direction, potential talent flight, and investor uncertainty.
“CEO transition announced with effective date Oct 31, 2026.”
5 Aug 202610-QHerbalife reported a net loss in Q2 2026 due to a $94.6M loss on debt extinguishment, despite revenue growth.earningsopen
Figures in the filing · each found in the filing text
| Net sales · Q2-2026 | $1.33B | +5% y/y |
| Net (loss) income attributable to Herbalife · Q2-2026 | $-26M | -153% y/y |
| Loss on extinguishment of debt · Q2-2026 | $95M |
Risks flagged
Debt refinancing risk
“During both the three and six months ended June 30, 2026, the Company recognized a $94.6 million loss on the extinguishment of the 2024 Credit Facility” · word for word
Profitability risk
“Net (loss) income attributable to Herbalife $ (26.3) for Q2 2026 vs $49.3 for Q2 2025” · word for word
5 Aug 20268-K · 2.02, 5.02, 7.01Net Sales $1.30B (+5% y/y); Net Loss Attributable to Herbalife $-26M; Adjusted EBITDA $167M; Guidance: Full-year adjusted EBITDA guidance narrowed to $670M-$690M from $675M-$705Mearningsopen
Figures in the filing · each found in the filing text
| Net Sales · Q2-2026 | $1.30B | +5% y/y |
| Net Loss Attributable to Herbalife · Q2-2026 | $-26M | |
| Adjusted EBITDA · Q2-2026 | $167M | |
| Adjusted Diluted EPS · Q2-2026 | $0.51 | |
| Gross Profit Margin · Q2-2026 | 77.7% | |
| Net Cash Provided by Operating Activities (YTD) · H1-2026 | $147M | |
| Capital Expenditures (YTD) · H1-2026 | $22M |
Guidance
Full-year adjusted EBITDA guidance narrowed to $670M-$690M from $675M-$705M
Q2 results at top of guidance; full-year guidance narrowed with constant currency raised, but FX headwinds lower reported EBITDA range
Risks flagged
FX headwinds impacting reported results and guidance
“Adjusted EBITDA includes approximately $7.6 million of FX headwinds year-over-year”
Loss on extinguishment of debt from refinancing
“Loss on extinguishment of debt of $94.6 million after successful April 2026 refinancing” · word for word
6 May 202610-QNet Sales $1.32B (+8% y/y); Gross Profit $1.03B (+7% y/y); Operating Income $138M (+13% y/y)open
Figures in the filing · each found in the filing text
| Net Sales · Consolidated · Q1-2026 | $1.32B | +8% y/y |
| Gross Profit · Consolidated · Q1-2026 | $1.03B | +7% y/y |
| Operating Income · Consolidated · Q1-2026 | $138M | +13% y/y |
| Net Income Attributable to Herbalife · Consolidated · Q1-2026 | $62M | +23% y/y |
| Earnings Per Diluted Share · Consolidated · Q1-2026 | $0.57 | +16% y/y |
| Operating Cash Flow · Consolidated · Q1-2026 | $114M | +56800% y/y |
Risks flagged
High leverage and debt refinancing risk
“Total debt $1,991.1M; shareholders' deficit $434.2M; refinancing completed in April 2026 with new 2033 notes.”
Foreign exchange volatility
“Foreign currency translation loss of $6.1M in Q1 2026 vs gain of $8.7M in Q1 2025.”
Dependence on China government grants
“Recognized $5.5M in China government grants in Q1 2026; no assurance of future grants.”
1 May 20268-K · 1.01, 2.03, 2.04, 8.01Herbalife issued $800M 7.750% Senior Secured Notes due 2033 and refinanced credit facilities with $225M Term A and $425M revolver, extending maturities and reducing leverage.open
Risks flagged
High leverage and refinancing risk; covenants require max total leverage 4.00x, first lien net leverage 2.50x, min fixed charge coverage 2.00x.
“Credit Agreement contains financial covenants: maximum total leverage ratio 4.00:1.00, maximum first lien net leverage ratio 2.50:1.00, minimum fixed charge coverage ratio 2.00:1.00.”
17 Mar 2026DEF 14AHerbalife filed its 2026 proxy statement (DEF 14A) disclosing executive compensation, governance, and shareholder proposals.open
Figures in the filing · each found in the filing text
| Net Sales · FY2025 | $5.00B | +1% y/y |
| Adjusted EBITDA · FY2025 | $635M | |
| Net Income · FY2025 | $228M | |
| Total Shareholder Return · FY2025 | $26.83 |
18 Feb 20268-K · 2.02, 7.01Net sales $1.30B (+6% y/y); Net income attributable to Herbalife $85M; Adjusted EBITDA $156M; Guidance: First quarter and full-year 2026 guidance providedearningsopen
Figures in the filing · each found in the filing text
| Net sales · Q4-2025 | $1.30B | +6% y/y |
| Net income attributable to Herbalife · Q4-2025 | $85M | |
| Adjusted EBITDA · Q4-2025 | $156M | |
| Diluted EPS · Q4-2025 | $0.81 | |
| Net sales (Full Year) · FY2025 | $5.00B | +1% y/y |
| Net income attributable to Herbalife (Full Year) · FY2025 | $228M | |
| Adjusted EBITDA (Full Year) · FY2025 | $658M | |
| Diluted EPS (Full Year) · FY2025 | $2.20 | |
| Net cash provided by operating activities (Full Year) · FY2025 | $333M | |
| Capital expenditures (Full Year) · FY2025 | $80M |
Guidance
First quarter and full-year 2026 guidance provided
Company provided Q1 and FY2026 guidance, indicating confidence in continued growth.
Risks flagged
Foreign exchange headwinds impacting reported results
“Full-year 2025 includes 160 basis points of FX headwind; adjusted EBITDA includes ~$56M FX headwind”
Input cost inflation pressuring gross margin
“Gross profit margin decline reflects 30 bps of input cost inflation driven by lower absorption rates”
18 Feb 202610-KEmployees 8,500open
Figures in the filing · each found in the filing text
| Employees · FY2025 | 8,500 |
Risks flagged
FTC Consent Order Compliance Risk
“The Consent Order, including our compliance therewith and the procedures implemented as a result thereof, has impacted, and may continue to impact, our business operations, including our net sales and profitability.” · word for word
Product Liability Self-Insurance Risk
“given the level of self-insured retentions that we have accepted under our current product liability insurance policies, which is $10 million, in certain cases we may be subject to the full amount of liability associated with any claims, which could be substantial.” · word for word
Network Marketing Program Legal Challenge Risk
“The failure of our network marketing program to comply with current or newly adopted laws, rules, and regulations, the Consent Order, or the California injunction, or any allegations or charges to that effect brought by federal, state, or foreign regulators, could have a material adverse impact our business in a particular market or in general and may advers” · word for word
5 Nov 20258-K · 2.02, 7.01Net Sales $1.30B (+3% y/y); Net Income Attributable to Herbalife $43M; Adjusted EBITDA $163M; Guidance: Full-year 2025 guidance tightened for net sales, adjusted EBITDA, and capital expendituresearningsopen
Figures in the filing · each found in the filing text
| Net Sales · Q3-2025 | $1.30B | +3% y/y |
| Net Income Attributable to Herbalife · Q3-2025 | $43M | |
| Adjusted EBITDA · Q3-2025 | $163M | |
| Diluted EPS · Q3-2025 | $0.42 | |
| Adjusted Diluted EPS · Q3-2025 | $0.50 | |
| Gross Margin · Q3-2025 | 77.7% | |
| Net Cash Provided by Operating Activities · Q3-2025 | $139M | |
| Capital Expenditures · Q3-2025 | $21M | |
| Total Leverage Ratio · Q3-2025 | 2.8 | |
| North America Net Sales Growth · North America · Q3-2025 | 1.0% |
Guidance
Full-year 2025 guidance tightened for net sales, adjusted EBITDA, and capital expenditures
Full-year 2025 guidance tightened, reflecting confidence in Q3 performance and outlook. Q4 guidance provided.
Risks flagged
Foreign currency headwinds impacting revenue and margins.
“Includes 50 basis points of FX headwinds; adjusted EBITDA includes approximately $12 million of FX headwinds YoY.”
Input cost inflation pressuring margins.
“30 basis points of input cost inflation, driven mainly by higher raw material costs.” · word for word
5 Nov 202510-QHerbalife reported Q3 2025 net sales of $1.27B (+2.7% YoY) and net income of $43.2M (-8.9% YoY), with mixed results across regions.earningsopen
Figures in the filing · each found in the filing text
| Net Sales · Q3-2025 | $1.27B | +3% y/y |
| Net Income Attributable to Herbalife · Q3-2025 | $43M | -9% y/y |
| Operating Cash Flow · 9M-2025 | $235M | +9% y/y |
| Free Cash Flow · 9M-2025 | $173M | |
| Gross Margin · Q3-2025 | 77.7% | |
| Net Sales - China · China · Q3-2025 | $71M | -5% y/y |
| Net Sales - India · India · Q3-2025 | $226M | +4% y/y |
| Net Sales - Mexico · Mexico · Q3-2025 | $147M | +12% y/y |
| Net Sales - Vietnam · Vietnam · Q3-2025 | $72M | +3% y/y |
| Net Sales - United States · United States · Q3-2025 | $256M | +1% y/y |
Risks flagged
China Revenue Decline
“The China region reported net sales of $71.3 million and $216.1 million for the three and nine months ended September 30, 2025, respectively. Net sales decreased $3.5 million, or 4.7%, and $15.6 million, or 6.7%.” · word for word
High Leverage and Interest Expense
“As of September 30, 2025, the weighted-average interest rate for borrowings under the 2024 Credit Facility was 11.66% and 10.35%, respectively.”
Tariff Exposure
“We continue to examine our cost structure and assess additional potential incremental pricing actions in response to ongoing inflationary pressures and any tariffs and retaliatory tariffs imposed by the U.S. or foreign governments which could have a significant adverse impact to our business, which includes our Mexico market where our U.S. manufacturing oper” · word for word
Foreign Exchange Volatility
“The 0.8% decrease in net sales for the nine months ended September 30, 2025 was primarily driven by a 2.3% unfavorable impact of fluctuations in foreign currency exchange rates.” · word for word
Regulatory and Legal Risks
“On October 31, 2024, the Company and certain of its executive officers were named as defendants in a purported class action lawsuit filed in the Los Angeles County Superior Court, titled Sarah DeSimone v. Herbalife Ltd. et al. The complaint alleges violations of the California Labor Code, including misclassification of distributors as independent contractors” · word for word
Herbalife Ltd. — questions
- What did Herbalife Ltd. file recently?
- 13 SEC filings in the last 12 months. Latest: 8-K on 2026-08-31 — CEO Stephan Gratziani to transition from role effective Oct 31, 2026, announced Aug 31, 2026. Departure of top executive signals potential strategic shift or instability.
Every figure on this page comes from Herbalife Ltd.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.